Nuwellis (NUWE) Return on Invested Capital (2015 - 2021)
Nuwellis (NUWE) posted Return on Invested Capital of 1.71% for Q3 2021, down 43.48% on a QoQ basis from 1.2% in Q2 2021, and up 97.0% year-over-year from 0.87% in Q3 2020.
Nuwellis (NUWE) Return on Invested Capital (2015 - 2021) Analysis & Trends
Nuwellis' Return on Invested Capital history runs 5 years deep, the most recent figure standing at 1.71% for Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.01% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.01% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.01% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.00% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.00% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nuwellis | 613.80 | -2.08 Mn | 1.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -1.71% |
| Jun 30, 2021 | -1.20% |
| Mar 31, 2021 | -0.90% |
| Dec 31, 2020 | -1.22% |
| Sep 30, 2020 | -2.69% |
| Mar 31, 2017 | -0.02% |
| Dec 31, 2016 | -0.02% |
| Sep 30, 2016 | -0.01% |
| Jun 30, 2016 | -0.02% |
| Mar 31, 2016 | -0.02% |
| Dec 31, 2015 | -0.04% |
| Sep 30, 2015 | -0.06% |
| Jun 30, 2015 | -0.16% |